These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. An unexpected player in Gaucher disease: The multiple roles of complement in disease development. Pandey MK; Grabowski GA; Köhl J Semin Immunol; 2018 Jun; 37():30-42. PubMed ID: 29478824 [TBL] [Abstract][Full Text] [Related]
6. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis. Carvelli J; Demaria O; Vély F; Batista L; Chouaki Benmansour N; Fares J; Carpentier S; Thibult ML; Morel A; Remark R; André P; Represa A; Piperoglou C; ; ; Cordier PY; Le Dault E; Guervilly C; Simeone P; Gainnier M; Morel Y; Ebbo M; Schleinitz N; Vivier E Nature; 2020 Dec; 588(7836):146-150. PubMed ID: 32726800 [TBL] [Abstract][Full Text] [Related]
7. The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics. Woodruff TM; Shukla AK Trends Immunol; 2020 Nov; 41(11):965-967. PubMed ID: 33023856 [TBL] [Abstract][Full Text] [Related]
8. Ras-Related Protein Rab5a Regulates Complement C5a Receptor Trafficking, Chemotaxis, and Chemokine Secretion in Human Macrophages. Wu KC; Condon ND; Hill TA; Reid RC; Fairlie DP; Lim J J Innate Immun; 2023; 15(1):468-484. PubMed ID: 36882040 [TBL] [Abstract][Full Text] [Related]
9. C5a drives the inflammatory response with bacterial dose effect by binding to C5aR1 in zebrafish infected with Aeromonas hydrophila. Liu X; Wang W; Tan S; Liu H; Li Z; Wang N; Ma J; Han S; Wu Z; Shi K; Sha Z Fish Shellfish Immunol; 2023 Aug; 139():108873. PubMed ID: 37271327 [TBL] [Abstract][Full Text] [Related]
10. [Involvement of the complement cascade in severe forms of COVID-19]. Chouaki Benmansour N; Carvelli J; Vivier É Med Sci (Paris); 2021 Apr; 37(4):333-341. PubMed ID: 33835019 [TBL] [Abstract][Full Text] [Related]
11. Complement cascade in severe forms of COVID-19: Recent advances in therapy. Chouaki Benmansour N; Carvelli J; Vivier E Eur J Immunol; 2021 Jul; 51(7):1652-1659. PubMed ID: 33738806 [TBL] [Abstract][Full Text] [Related]
12. COVID-19: A collision of complement, coagulation and inflammatory pathways. Chauhan AJ; Wiffen LJ; Brown TP J Thromb Haemost; 2020 Sep; 18(9):2110-2117. PubMed ID: 32608159 [TBL] [Abstract][Full Text] [Related]
14. Modelling and analysis of the complement system signalling pathways: roles of C3, C5a and pro-inflammatory cytokines in SARS-CoV-2 infection. Murad D; Zafar Paracha R; Saeed MT; Ahmad J; Mushtaq A; Humayun M PeerJ; 2023; 11():e15794. PubMed ID: 37744234 [TBL] [Abstract][Full Text] [Related]
15. Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV. Jiang Y; Zhao G; Song N; Li P; Chen Y; Guo Y; Li J; Du L; Jiang S; Guo R; Sun S; Zhou Y Emerg Microbes Infect; 2018 Apr; 7(1):77. PubMed ID: 29691378 [TBL] [Abstract][Full Text] [Related]
16. C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis. Zheng QY; Liang SJ; Xu F; Li GQ; Luo N; Wu S; Li Y; Tang M; Zhong Y; Chen J; Yang D; Sun DD; Zhang KQ; Xu GL Front Immunol; 2019; 10():1866. PubMed ID: 31447855 [TBL] [Abstract][Full Text] [Related]
17. Pre-existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patients. Pandey MK Clin Transl Discov; 2022 Jun; 2(2):e96. PubMed ID: 35942236 [TBL] [Abstract][Full Text] [Related]
18. The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin. Sadik CD; Miyabe Y; Sezin T; Luster AD Semin Immunol; 2018 Jun; 37():21-29. PubMed ID: 29602515 [TBL] [Abstract][Full Text] [Related]
19. C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19. Aiello S; Gastoldi S; Galbusera M; Ruggenenti P; Portalupi V; Rota S; Rubis N; Liguori L; Conti S; Tironi M; Gamba S; Santarsiero D; Benigni A; Remuzzi G; Noris M Blood Adv; 2022 Jan; 6(3):866-881. PubMed ID: 34852172 [TBL] [Abstract][Full Text] [Related]
20. The Complement System Component C5a Produces Thermal Hyperalgesia via Macrophage-to-Nociceptor Signaling That Requires NGF and TRPV1. Shutov LP; Warwick CA; Shi X; Gnanasekaran A; Shepherd AJ; Mohapatra DP; Woodruff TM; Clark JD; Usachev YM J Neurosci; 2016 May; 36(18):5055-70. PubMed ID: 27147658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]